HGWM
AMED

Harvest Group Wealth Management’s Amedisys AMED Stock Holding History

Harvest Group Wealth Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-10
Closed -$3K – 65
2020
Q4 		$3K Hold
10
– – ﹤0.01% 287
2020
Q3 		$2K Hold
10
– – ﹤0.01% 321
2020
Q2 		$1K Hold
10
– – ﹤0.01% 347
2020
Q1 		$1K Sell
10
-8
-44% -$1.42K ﹤0.01% 348
2019
Q4 		$3K Hold
18
– – ﹤0.01% 479
2019
Q3 		$2K Hold
18
– – ﹤0.01% 630
2019
Q2 		$2K Hold
18
– – ﹤0.01% 502
2019
Q1 		$2K Buy
+18
New +$2.26K ﹤0.01% 578

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Harvest Group Wealth Management's AMED Position: Q1 2021 in Review

Harvest Group Wealth Management sold out of Amedisys (AMED) in Q1 2021, closing a stake of 10 shares — an estimated $3K sold.

Harvest Group Wealth Management first reported a position in AMED in Q1 2019 and held it in 8 quarters. The position peaked at $3K in Q4 2020. 388 funds tracked by Wall St. Rank hold AMED as of Q1 2021.

  • Harvest Group Wealth Management reported no remaining Amedisys position as of Q1 2021 after selling out during the quarter.
  • Harvest Group Wealth Management sold 10 Amedisys shares in Q1 2021, an estimated $3K.
  • Harvest Group Wealth Management first reported a position in Amedisys in Q1 2019 and held it in 8 quarters.
  • Harvest Group Wealth Management's Amedisys position peaked at $3K in Q4 2020.
  • 388 funds tracked by Wall St. Rank held Amedisys as of Q1 2021.

Based on Harvest Group Wealth Management's 13F filing for Q1 2021, filed 4 May 2021.